Recall Z-1923-2026— Remel Europe Ltd.

Class II · Ongoing

Class II FDA medical device recall by Remel Europe Ltd., initiated 2026-03-25. FDA's recall record names no specific 510(k) clearance for this event. Product: Oxoid Agglutinating Sera, Salmonella 9-0 R30957301. Reason: Affected lots are not performing to IFU criteria showing cross reactions with 2-0 within 60 seconds. Cross-reactivity may result in the misidentification of a Salmonella 9-O serotype as a 2-O serotype..

Recalling firm
Remel Europe Ltd.
Classification
Class II
Status
Ongoing
Initiated
2026-03-25
Firm location
Dartford, N/A, United Kingdom

Product description

Oxoid Agglutinating Sera, Salmonella 9-0 R30957301

Reason for recall

Affected lots are not performing to IFU criteria showing cross reactions with 2-0 within 60 seconds. Cross-reactivity may result in the misidentification of a Salmonella 9-O serotype as a 2-O serotype.

Data sourced from openFDA. This site is unofficial and independent of the FDA.